Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...